Contribution of macrophages in the HSC niche
巨噬细胞在 HSC 生态位中的贡献
基本信息
- 批准号:10213515
- 负责人:
- 金额:$ 56.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AnimalsApplications GrantsBlood VesselsBone MarrowCD47 geneCRISPR/Cas technologyCSF3 geneCXCL12 geneCell CommunicationCell MaintenanceCellsCellular StructuresCollaborationsConnexin 43ConnexinsDataDevelopmentEmbryoEquilibriumErythroblastsErythrocytesErythroidFundingGJB3 geneGenerationsGenesGeneticGenetic ModelsHematological DiseaseHematopoieticHematopoietic Stem Cell MobilizationHematopoietic Stem Cell heterogeneityHematopoietic stem cellsImageImmunofluorescence ImmunologicIn TransferrinIronIslandLaboratoriesLeadLightLiver X ReceptorMediatingMethodsMolecularMusMyelogenousNational Heart, Lung, and Blood InstituteNatural regenerationPathway interactionsPhagocytesPopulationProcessProductionRegulationRoleSeriesSignal TransductionSingaporeStromal CellsStructureSynapsesTFRC geneUniversitiesWorkblood treatmenterythroid differentiationexperimental studygenotoxicitygut microbiotahematopoietic stem cell differentiationhematopoietic stem cell nichehematopoietic stem cell self-renewalmacrophagemetal transporting protein 1microbiotanovelnovel therapeutic interventionprogenitorregeneration functionresidencesenescencespatial relationshipstem cell functionstem cellstranscriptome sequencing
项目摘要
PROJECT SUMMARY:
Previous studies from our laboratory have suggested that CD169+ macrophages of the bone marrow (BM)
contribute to the hematopoietic stem cell (HSC) niche activity by regulating CXCL12 synthesis in stromal cells and
their retention in the BM. Preliminary results reveal two novel functions of macrophages in directly regulating the
HSC function. First, we provide evidence that macrophages are critical for HSC regeneration after genotoxic
challenge via the regulation of iron availability mediated by signals from the gut microbiota. Second, we have
found that BM macrophages can transfer to HSCs/progenitors key retention signals that confer residence in BM.
Indeed, HSCs that have received the transfer from macrophages are retained in the BM, whereas only those that
have not are mobilized from the BM microenvironment following G-CSF administration. These results raise
important new questions as to whether the various functions of macrophages in regulating HSCs, RBC
production, or clearance are achieved by the same cells or whether the BM macrophages have specialized
functions. In this proposal, we will explore the hypothesis that macrophage can directly contribute to niche
activities by regulating HSCs’ ability to regenerate and to egress from the BM. In Specific Aim 1, we will
investigate how macrophages interact with the microbiota to promote HSC regeneration. We will use genetic
models to manipulate iron delivery pathways in HSCs and macrophages to dissect the mechanism by which iron
is supplied to HSCs/progenitors during hematopoietic regeneration. We will also evaluate how BM macrophages
can sense signals from the microbiota. In Specific Aim 2, we will investigate the mechanisms by which
macrophages assign bone marrow residence. We will assess the role of connexins in the cell-cell communication
using CRISPR/Cas9-mediated targeting and determine the role of trogocytosis as transfer mechanism. In Specific
Aim 3, we will further define the bone marrow-resident macrophage population. We will evaluate the spatial
relationship of these macrophages with vascular structures, HSCs and erythroblasts using immunofluorescence
imaging. We will investigate the origin (embryonic or hematopoietic) of BM- resident macrophages using genetic
tracing methods. These studies will shed light into the critical functions of an under-appreciated component of the
HSC niche and uncover new therapeutic approaches for blood disorders.
项目摘要:
我们实验室的先前研究表明,骨髓(BM)的CD169+巨噬细胞
通过调节基质细胞中的CXCL12合成和
他们保留在BM中。初步结果揭示了直接调节巨噬细胞的两个新功能
HSC功能。首先,我们提供证据表明巨噬细胞对于遗传毒性后HSC再生至关重要。
通过调节肠道菌群信号介导的铁可用性的挑战。第二,我们有
发现BM巨噬细胞可以转移到BM会议居住地的HSC/祖先关键保留信号。
实际上,从巨噬细胞转移的HSC保留在BM中,而只有那些
G-CSF给药后,尚未从BM微环境中动员。这些结果提高了
关于巨噬细胞在调节HSC中的各种功能,RBC的重要新问题
同一单元格或BM巨噬细胞是否专业实现生产或清除率
功能。在此提案中,我们将探讨巨噬细胞可以直接有助于利基的假设
通过规范HSC的再生能力和从BM出口的能力来进行活动。在特定目标1中,我们将
研究巨噬细胞如何与菌群相互作用以促进HSC再生。我们将使用遗传
在HSC和巨噬细胞中操纵铁发射途径的模型,以剖析铁的机制
在造血再生期间提供给HSC/祖细胞。我们还将评估BM巨噬细胞的方式
可以感觉到微生物群的信号。在特定的目标2中,我们将研究的机制
巨噬细胞分配骨髓住所。我们将评估连接蛋白在细胞电池通信中的作用
使用CRISPR/CAS9介导的靶向,并确定trogocytosis作为转移机制的作用。具体
AIM 3,我们将进一步定义骨髓居民巨噬细胞种群。我们将评估空间
这些巨噬细胞与使用免疫荧光的血管结构,HSC和红细胞的关系
成像。我们将使用通用性研究BM居民巨噬细胞的起源(胚胎或造血)
跟踪方法。这些研究将介绍到未注重的成分的关键功能中
HSC利基市场和血液疾病的新治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ulrich Steidl其他文献
Ulrich Steidl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ulrich Steidl', 18)}}的其他基金
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting
白血病前期干细胞的分子和细胞调控及其治疗靶向
- 批准号:
10478927 - 财政年份:2021
- 资助金额:
$ 56.04万 - 项目类别:
Contribution of macrophages in the HSC niche
巨噬细胞在 HSC 生态位中的贡献
- 批准号:
10571821 - 财政年份:2021
- 资助金额:
$ 56.04万 - 项目类别:
Contribution of macrophages in the HSC niche
巨噬细胞在 HSC 生态位中的贡献
- 批准号:
10374928 - 财政年份:2021
- 资助金额:
$ 56.04万 - 项目类别:
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting
白血病前期干细胞的分子和细胞调控及其治疗靶向
- 批准号:
10299704 - 财政年份:2021
- 资助金额:
$ 56.04万 - 项目类别:
STAT3 inhibition as a therapeutic strategy against MDS stem cells
STAT3 抑制作为针对 MDS 干细胞的治疗策略
- 批准号:
10443583 - 财政年份:2019
- 资助金额:
$ 56.04万 - 项目类别:
STAT3 inhibition as a therapeutic strategy against MDS stem cells
STAT3 抑制作为针对 MDS 干细胞的治疗策略
- 批准号:
10206262 - 财政年份:2019
- 资助金额:
$ 56.04万 - 项目类别:
Mechanisms of Formation and Progression of Preleukemic Stem Cells
白血病前期干细胞的形成和进展机制
- 批准号:
9890782 - 财政年份:2017
- 资助金额:
$ 56.04万 - 项目类别:
相似海外基金
Diversity Supplement for Angiogenic and anti-microbial supports for pulp regeneration
用于牙髓再生的血管生成和抗微生物支持的多样性补充剂
- 批准号:
10889680 - 财政年份:2023
- 资助金额:
$ 56.04万 - 项目类别:
Biogenesis and Catabolism of Atherogenic Lipoproteins
致动脉粥样硬化脂蛋白的生物发生和分解代谢
- 批准号:
10628985 - 财政年份:2023
- 资助金额:
$ 56.04万 - 项目类别:
Development of an INSPIRE System for the Treatment of Inoperable Liver Tumors
开发用于治疗无法手术的肝脏肿瘤的 INSPIRE 系统
- 批准号:
10560677 - 财政年份:2023
- 资助金额:
$ 56.04万 - 项目类别:
Advanced Small Animal Ultrasound Imaging - Vevo F2
先进的小动物超声成像 - Vevo F2
- 批准号:
10632878 - 财政年份:2023
- 资助金额:
$ 56.04万 - 项目类别:
Angiogenic and anti-microbial supports for pulp regeneration
用于牙髓再生的血管生成和抗菌支持
- 批准号:
10578730 - 财政年份:2022
- 资助金额:
$ 56.04万 - 项目类别: